Attached files
| file | filename |
|---|---|
| EX-32.2 - MyMD Pharmaceuticals, Inc. | ex32-2.htm |
| EX-32.1 - MyMD Pharmaceuticals, Inc. | ex32-1.htm |
| EX-31.2 - MyMD Pharmaceuticals, Inc. | ex31-2.htm |
| EX-31.1 - MyMD Pharmaceuticals, Inc. | ex31-1.htm |
| EX-21.1 - MyMD Pharmaceuticals, Inc. | ex21-1.htm |
| EX-4.1 - MyMD Pharmaceuticals, Inc. | ex4-1.htm |
| 10-K - MyMD Pharmaceuticals, Inc. | form10-k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-1 (File No. 333-234447 and 333-235359) and Form S-3 (File No. 333-217390, 333-234449, 333-238631 and 333-248095) of Akers Biosciences, Inc. of our report dated March 1, 2021 relating to the consolidated financial statements, which appears in this Form 10-K.
/s/ Morison Cogen LLP
Blue Bell, Pennsylvania
March 1, 2021